.jpg)
.png)
Features
October 6, 2025
Amgen Makes Repatha® Available Through AmgenNow, A Direct-to-patient Program in the US
THOUSAND OAKS, Calif., Oct. 6, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the launch...
Read More...August 25, 2025
REPATHA® NOW INDICATED FOR ADULTS AT INCREASED RISK FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS DUE TO UNCONTROLLED LDL-C
THOUSAND OAKS, Calif., Aug. 25, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food...
Read More...June 20, 2025
National Lipid Association Releases New Guidance: “LDL Cholesterol Management Simplified in Adults – Lower for Longer is Better”
The National Lipid Association (NLA) today announced the release of a major new clinical guidance document titled “LDL...
Read More...May 28, 2025
Multidisciplinary Teams in Clinical Lipidology and Cardiometabolic Care: A National Lipid Association Expert Clinical Review
This Expert Clinical Review highlights the importance of a collaborative approach to the management of dyslipidemia and...
Read More...May 19, 2025
NLA and FNLA Urge CMS and Administrator Oz to Include Low-Density Lipoprotein Cholesterol (LDL-C) Measurement in CMS Quality Measurement Programs
The National Lipid Association (NLA) and Foundation of the National Lipid Association (Foundation) urge the Centers for...
Read More...